[THE PHARMACOLOGIC PROPERTIES OF A NEW ANTIFIBRINOLYTIC, PARA-AMINOMETHYLBENZOIC ACID].
D010129:4-Aminobenzoic Acid; D000614:Aminocaproates; D015119:Aminocaproic Acid; D000889:Anti-Arrhythmia Agents; D000933:Antifibrinolytic Agents; D001769:Blood; D002845:Chromatography; D003124:Colorimetry; D005342:Fibrinolysis; D008660:Metabolism; D010600:Pharmacology; D051381:Rats; D012106:Research; D013916:Thrombelastography; D014116:Toxicology; D014556:Urine; D062366:para-Aminobenzoates
D000614:Aminocaproates; D000889:Anti-Arrhythmia Agents; D000933:Antifibrinolytic Agents; D062366:para-Aminobenzoates; C015668:4-aminomethylbenzoic acid; D010129:4-Aminobenzoic Acid; D015119:Aminocaproic Acid
AMINOBENZOIC ACID; AMINOCAPROIC ACID; BLOOD; CHROMATOGRAPHY; COLORIMETRY; EXPERIMENTAL LAB STUDY; FIBRINOLYSIS; METABOLISM; MYOCARDIAL DEPRESSANTS; PHARMACOLOGY; RATS; THROMBOELASTOGRAPHY; TOXICOLOGIC REPORT; URINE
DIE PHARMAKOLOGISCHE CHARAKTERISIERUNG DES NEUEN ANTIFIBRINOLYTIKUMS P-AMINOMETHYLBENZOESAEURE (PAMBA)